ID   ALLC_ACIAD              Reviewed;         334 AA.
AC   Q6F6Y1;
DT   13-SEP-2005, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   03-AUG-2022, entry version 109.
DE   RecName: Full=Probable allantoicase {ECO:0000255|HAMAP-Rule:MF_00813};
DE            EC=3.5.3.4 {ECO:0000255|HAMAP-Rule:MF_00813};
DE   AltName: Full=Allantoate amidinohydrolase {ECO:0000255|HAMAP-Rule:MF_00813};
GN   Name=alc {ECO:0000255|HAMAP-Rule:MF_00813}; OrderedLocusNames=ACIAD3541;
OS   Acinetobacter baylyi (strain ATCC 33305 / BD413 / ADP1).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Moraxellales; Moraxellaceae;
OC   Acinetobacter.
OX   NCBI_TaxID=62977;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 33305 / BD413 / ADP1;
RX   PubMed=15514110; DOI=10.1093/nar/gkh910;
RA   Barbe V., Vallenet D., Fonknechten N., Kreimeyer A., Oztas S., Labarre L.,
RA   Cruveiller S., Robert C., Duprat S., Wincker P., Ornston L.N.,
RA   Weissenbach J., Marliere P., Cohen G.N., Medigue C.;
RT   "Unique features revealed by the genome sequence of Acinetobacter sp. ADP1,
RT   a versatile and naturally transformation competent bacterium.";
RL   Nucleic Acids Res. 32:5766-5779(2004).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=allantoate + H2O = (S)-ureidoglycolate + urea;
CC         Xref=Rhea:RHEA:11016, ChEBI:CHEBI:15377, ChEBI:CHEBI:16199,
CC         ChEBI:CHEBI:17536, ChEBI:CHEBI:57296; EC=3.5.3.4;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_00813};
CC   -!- PATHWAY: Nitrogen metabolism; (S)-allantoin degradation; (S)-
CC       ureidoglycolate from allantoate (aminidohydrolase route): step 1/1.
CC       {ECO:0000255|HAMAP-Rule:MF_00813}.
CC   -!- SIMILARITY: Belongs to the allantoicase family. {ECO:0000255|HAMAP-
CC       Rule:MF_00813}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CR543861; CAG70184.1; -; Genomic_DNA.
DR   RefSeq; WP_004923271.1; NC_005966.1.
DR   AlphaFoldDB; Q6F6Y1; -.
DR   SMR; Q6F6Y1; -.
DR   STRING; 62977.ACIAD3541; -.
DR   EnsemblBacteria; CAG70184; CAG70184; ACIAD3541.
DR   GeneID; 45235717; -.
DR   KEGG; aci:ACIAD3541; -.
DR   eggNOG; COG4266; Bacteria.
DR   HOGENOM; CLU_038797_1_2_6; -.
DR   OMA; MDDGWET; -.
DR   OrthoDB; 651058at2; -.
DR   BioCyc; ASP62977:ACIAD_RS16015-MON; -.
DR   UniPathway; UPA00395; UER00654.
DR   Proteomes; UP000000430; Chromosome.
DR   GO; GO:0004037; F:allantoicase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0000256; P:allantoin catabolic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0006144; P:purine nucleobase metabolic process; IEA:UniProtKB-KW.
DR   HAMAP; MF_00813; Allantoicase; 1.
DR   InterPro; IPR005164; Allantoicase.
DR   InterPro; IPR015908; Allantoicase_dom.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   PANTHER; PTHR12045; PTHR12045; 1.
DR   Pfam; PF03561; Allantoicase; 2.
DR   PIRSF; PIRSF016516; Allantoicase; 1.
DR   SUPFAM; SSF49785; SSF49785; 2.
DR   TIGRFAMs; TIGR02961; allantoicase; 1.
PE   3: Inferred from homology;
KW   Hydrolase; Purine metabolism; Reference proteome.
FT   CHAIN           1..334
FT                   /note="Probable allantoicase"
FT                   /id="PRO_0000205916"
SQ   SEQUENCE   334 AA;  37395 MW;  3ED8B79516370EC2 CRC64;
     MATLLAPAFE LPTSLHSLTN LADSRIGAQI VECSDDFFAE AKRMLQFEAP IFVEDKFDDH
     GKWMDGWETR RKRHAGYDWC IVKLGVAGKI KAVDIDTTFF TGNYPASASL EGCYAPNGNT
     QEALWQPLLG NSILGPSQHH VFDVQNDAIF THIRLNIFPD GGVARLRIYG DVQIQITDTD
     QTLDLLALQN GGRVIAYSDA HFGHPRNLIN PGRGVNMGDG WETKRRRAPG FDWCLLALGQ
     AGKIEKIEID TAHFKGNYPA QVSIQAIYIE DATDPQLIPQ SMFWPFLLEA QDMQMDHIHS
     YLNEVLAHEK VSHIRVNMIP DGGISRVRLW GKVV